Page 7 of 10 – SEC Filing CUSIP NO.
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J); (k) [ ] Group, in accordance with §240.13d-1(b)(1)(ii)(K).
Item 4. Ownership***
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned*** Cormorant Global Healthcare Master Fund, LP – 1,658,151 shares
Cormorant Global Healthcare GP, LLC – 1,658,151 shares
Cormorant Asset Management, LLC – 1,988,208 shares
Bihua Chen – 1,988,208 shares (b) Percent of Class Cormorant Global Healthcare Master Fund, LP – 8.5%
Cormorant Global Healthcare GP, LLC – 8.5%
Cormorant Asset Management, LLC – 10.1%
Bihua Chen – 10.1% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote
Follow Clearside Biomedical Inc.
Follow Clearside Biomedical Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP NO. |
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) | [ ] | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). | |
| (b) | [ ] | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). | |
| (c) | [ ] | Insurance Company as defined in Section 3(a)(19) of the Act | |
| (d) | [ ] | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
| (e) | [ ] | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | |
| (f) | [ ] | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | |
| (g) | [ ] | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) | [ ] | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) | [ ] | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | [ ] | A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J); | |
| (k) | [ ] | Group, in accordance with §240.13d-1(b)(1)(ii)(K). |
| Item 4. | Ownership*** |
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
| (a) | Amount Beneficially Owned*** | ||
| Cormorant Global Healthcare Master Fund, LP – 1,658,151 shares Cormorant Global Healthcare GP, LLC – 1,658,151 shares Cormorant Asset Management, LLC – 1,988,208 shares Bihua Chen – 1,988,208 shares | |||
| (b) | Percent of Class | ||
| Cormorant Global Healthcare Master Fund, LP – 8.5% Cormorant Global Healthcare GP, LLC – 8.5% Cormorant Asset Management, LLC – 10.1% Bihua Chen – 10.1% | |||
| (c) | Number of shares as to which such person has: | ||
| (i) | sole power to vote or to direct the vote | ||
Follow Clearside Biomedical Inc.
Follow Clearside Biomedical Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
